促排卵周期中的黄体支持  

Luteal support in stimulated ovulation cycle

作　　者：刘冬娥[1] 

机构地区：[1]中南大学湘雅医院生殖医学中心,湖南长沙410008

出　　处：《中国实用妇科与产科杂志》2015年第1期35-38,共4页Chinese Journal of Practical Gynecology and Obstetrics

摘　　要：促排卵治疗是不孕症治疗过程中常见的治疗手段,亦是辅助生殖技术的重要环节,促排卵治疗后导致的黄体功能不全及对子宫内膜功能的影响,导致胚胎着床失败,妊娠率下降。临床研究提示黄体支持有助于改善促排卵周期的妊娠结局。目前尚无公认的最佳黄体支持方案,黄体支持的药物主要包括人绒毛膜促性腺激素(HCG)、黄体酮、雌激素及促性腺激素释放激素激动剂(Gn RH-a)。药物使用的种类、剂型和使用时间无统一标准。Stimulating ovulation is a common treatment in the process of infertility treatment, it is also an important part of assisted reproductive technology. Stimulating ovulation may result in luteal phase insufficiency and its effect on endometrium may cause the failure of the embryo implantation, declining of pregnancy rate. Clinical studies suggest luteal support could help pregnancy outcomes in stimulated cycles. There was no generally accepted best luteal support scheme, luteal support drugs mainly include HCG, progesterone and estrogen and GnRH-a. The standards of drug choice, drug delivery methods, dosage form as well as the time of administration are not formed.

关 键 词：促排卵 黄体功能不全 黄体支持 

分 类 号：R321-33[医药卫生—人体解剖和组织胚胎学]